Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $23.9 million.

  • Abivax's Interest & Investment Income rose 53213.23% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.2 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 8060.73% up from last year.
  • As of Q3 2025, Abivax's Interest & Investment Income stood at $23.9 million, which was up 53213.23% from $4.0 million recorded in Q2 2025.
  • Over the past 5 years, Abivax's Interest & Investment Income peaked at $24.5 million during Q4 2024, and registered a low of -$1.1 million during Q1 2025.